AMGN Amgen Inc.

438.82USD-1.14%Mkt Cap: 237.36B USDP/E: 25.44

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthriti…